- Home
- Publications
- Publication Search
- Publication Details
Title
New approaches to gene and cell therapy for hemophilia
Authors
Keywords
-
Journal
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Volume 13, Issue -, Pages S133-S142
Publisher
Wiley
Online
2015-06-21
DOI
10.1111/jth.12926
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- AAV liver expression of FIX-Padua prevents and eradicates FIX inhibitor without increasing thrombogenicity in hemophilia B dogs and mice
- (2015) J. M. Crudele et al. BLOOD
- Omental implantation of BOECs in hemophilia dogs results in circulating FVIII antigen and a complex immune response
- (2014) M. C. Ozelo et al. BLOOD
- Murine coagulation factor VIII is synthesized in endothelial cells
- (2014) L. A. Everett et al. BLOOD
- Computationally designed liver-specific transcriptional modules and hyperactive factor IX improve hepatic gene therapy
- (2014) N. Nair et al. BLOOD
- Current status of haemophilia gene therapy
- (2014) K. H. High et al. HAEMOPHILIA
- Promoterless gene targeting without nucleases ameliorates haemophilia B in mice
- (2014) A. Barzel et al. NATURE
- Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B
- (2014) Amit C. Nathwani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeted inversion and reversion of the blood coagulation factor 8 gene in human iPS cells using TALENs
- (2014) C.-Y. Park et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Costs and utilization of hemophilia A and B patients with and without inhibitors
- (2014) Edward P. Armstrong et al. JOURNAL OF MEDICAL ECONOMICS
- Robust ZFN-mediated genome editing in adult hemophilic mice
- (2013) X. M. Anguela et al. BLOOD
- Development of gene therapy for blood disorders: an update
- (2013) A. W. Nienhuis BLOOD
- Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant
- (2013) J. McIntosh et al. BLOOD
- Effective gene therapy for haemophilic mice with pathogenic factor IX antibodies
- (2013) David M. Markusic et al. EMBO Molecular Medicine
- Liver gene therapy by lentiviral vectors reverses anti-factor IX pre-existing immunity in haemophilic mice
- (2013) Andrea Annoni et al. EMBO Molecular Medicine
- Production of functional coagulation factor VIII from iPSCs using a lentiviral vector
- (2013) Y. Kashiwakura et al. HAEMOPHILIA
- Genetically Modified Adipose Tissue-Derived Stem/Stromal Cells, Using Simian Immunodeficiency Virus-Based Lentiviral Vectors, in the Treatment of Hemophilia B
- (2013) Natsumi Watanabe et al. HUMAN GENE THERAPY
- The prevalence of neutralizing antibodies against adeno-associated virus capsids is reduced in young Japanese individuals
- (2013) Jun Mimuro et al. JOURNAL OF MEDICAL VIROLOGY
- Platelet Gene Therapy by Lentiviral Gene Delivery to Hematopoietic Stem Cells Restores Hemostasis and Induces Humoral Immune Tolerance in FIXnull Mice
- (2013) Yingyu Chen et al. MOLECULAR THERAPY
- Selection and evaluation of clinically relevant AAV variants in a xenograft liver model
- (2013) Leszek Lisowski et al. NATURE
- A Novel Cell-Sheet Technology That Achieves Durable Factor VIII Delivery in a Mouse Model of Hemophilia A
- (2013) Kohei Tatsumi et al. PLoS One
- Platelet-targeted gene therapy with human factor VIII establishes haemostasis in dogs with haemophilia A
- (2013) Lily M. Du et al. Nature Communications
- Hyperfunctional coagulation factor IX improves the efficacy of gene therapy in hemophilic mice
- (2012) A. Cantore et al. BLOOD
- The efficacy and the risk of immunogenicity of FIX Padua (R338L) in hemophilia B dogs treated by AAV muscle gene therapy
- (2012) J. D. Finn et al. BLOOD
- Intra-articular injection of mesenchymal stem cells expressing coagulation factor ameliorates hemophilic arthropathy in factor VIII-deficient mice
- (2012) Y. KASHIWAKURA et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Endgame: Glybera Finally Recommended for Approval as the First Gene Therapy Drug in the European Union
- (2012) Seppo Ylä-Herttuala MOLECULAR THERAPY
- Minimizing the Inhibitory Effect of Neutralizing Antibody for Efficient Gene Expression in the Liver With Adeno-associated Virus 8 Vectors
- (2012) Jun Mimuro et al. MOLECULAR THERAPY
- Transient B Cell Depletion or Improved Transgene Expression by Codon Optimization Promote Tolerance to Factor VIII in Gene Therapy
- (2012) Brandon K. Sack et al. PLoS One
- Porcine Model of Hemophilia A
- (2012) Yuji Kashiwakura et al. PLoS One
- Hepatocyte-targeted expression by integrase-defective lentiviral vectors induces antigen-specific tolerance in mice with low genotoxic risk
- (2011) Janka Mátrai et al. HEPATOLOGY
- Good Manufacturing Practice Production of Self-Complementary Serotype 8 Adeno-Associated Viral Vector for a Hemophilia B Clinical Trial
- (2011) James A. Allay et al. HUMAN GENE THERAPY
- A MicroRNA-regulated and GP64-pseudotyped Lentiviral Vector Mediates Stable Expression of FVIII in a Murine Model of Hemophilia A
- (2011) Hideto Matsui et al. MOLECULAR THERAPY
- In vivo genome editing restores haemostasis in a mouse model of haemophilia
- (2011) Hojun Li et al. NATURE
- Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B
- (2011) Amit C. Nathwani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hierarchical scaffold design for mesenchymal stem cell-based gene therapy of hemophilia B
- (2010) Daniel L. Coutu et al. BIOMATERIALS
- Targeting FVIII expression to endothelial cells regenerates a releasable pool of FVIII and restores hemostasis in a mouse model of hemophilia A
- (2010) Q. Shi et al. BLOOD
- Liver-restricted expression of the canine factor VIII gene facilitates prevention of inhibitor formation in factor VIII-deficient mice
- (2009) Akira Ishiwata et al. JOURNAL OF GENE MEDICINE
- Supplying Clotting Factors From Hematopoietic Stem Cell–derived Erythroid and Megakaryocytic Lineage Cells
- (2009) Michel Sadelain et al. MOLECULAR THERAPY
- A Simplified Baculovirus-AAV Expression Vector System Coupled With One-step Affinity Purification Yields High-titer rAAV Stocks From Insect Cells
- (2009) Richard H Smith et al. MOLECULAR THERAPY
- Phenotypic correction of murine hemophilia A using an iPS cell-based therapy
- (2009) Dan Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Intraarticular factor IX protein or gene replacement protects against development of hemophilic synovitis in the absence of circulating factor IX
- (2008) J. Sun et al. BLOOD
- Analysis of the spatial and temporal characteristics of platelet-delivered factor VIII-based clots
- (2008) M. Neyman et al. BLOOD
- Platelet-delivered factor VIII provides limited resistance to anti-factor VIII inhibitors
- (2008) J. GEWIRTZ et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Phenotypic Correction of Hemophilia A by Ectopic Expression of Activated Factor VII in Platelets
- (2008) Tsukasa Ohmori et al. MOLECULAR THERAPY
- Prolonged Susceptibility to Antibody-mediated Neutralization for Adeno-associated Vectors Targeted to the Liver
- (2007) Samuel L Murphy et al. MOLECULAR THERAPY
- Optimization of Self-complementary AAV Vectors for Liver-directed Expression Results in Sustained Correction of Hemophilia B at Low Vector Dose
- (2007) Zhijian Wu et al. MOLECULAR THERAPY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started